The Josep Carreras Leukaemia Research Institute (IJC) is a non-profit research institute based in Barcelona dedicated to advancing the understanding of leukemia and related disorders, in collaboration with the University of Barcelona and the Autonomous University of Barcelona. The IJC has laboratories in 5 clinical campuses: i) Hospital Clínic, ii) Hospital de Sant Pau and iii) Hospital Germans Trias and Pujol and iv) Hospital del Mar and v) Hospital Josep Trueta. IJC serves as a collaborative center for basic researchers and physicians to work together on fundamental clinical and biological aspects of leukemia. IJC offers an excellent work environment based on a multidisciplinary fusion of state-of-the-art ideas and facilities.
We are searching for a highly motivated researcher interested in answering basic and translational biological questions in close collaboration with preclinical scientists and physicians.
The selected candidate will be involved in 2 projects:
· Next-generation Gamma Delta CAR T-cells for allogeneic adoptive cancer immunotherapy, funded by “la Caixa” Foundation (ID 100010434) under the agreement LCF/PR/HR19/
· Alternative splicing and cancer neoantigens in acute leukemia (CANCERNA), that receives funding from the European Union's Horizon Europe Research and Innovation Programme under Grant Agreement No 101057250.
All the information are in the attached document.
Entidad Financiadora: Instituto Investigación contra la leucemia Josep Carreras
Plazo de Presentación: -